Press release

DNAnexus Appoints Scott Gibson as Chief Financial Officer

Sponsored by Businesswire

DNAnexus, Inc., the leader in biomedical informatics and data
management, today announced the appointment of Scott Gibson as Chief
Financial Officer. In this role, Gibson will lead finance, legal, human
resources, and administration.

This press release features multimedia. View the full release here:

Scott Gibson (Photo: Business Wire)

Scott Gibson (Photo: Business Wire)

“Scott’s diverse background and skill set have helped him grow
successful technology businesses over his 30-year career,” said Richard
Daly, Chief Executive Officer of DNAnexus. “His recent experience in
scaling a SaaS business model coupled with his proficiency overseeing
financial planning and analysis will be of great value to DNAnexus as we
continue on a strong growth trajectory.”

Gibson has held CFO roles at both public and private firms that cover a
broad swath of the tech industry. Prior to joining DNAnexus, Gibson
served as CFO at Conviva, a leading data analytics software platform
firm in the media space. Previously, he was CFO at several
semiconductor, semiconductor equipment, and networking companies. Gibson
received his Bachelor of Science in industrial engineering from Iowa
State University and his Master of Business Administration from the
Stephen M. Ross School of Business at the University of Michigan.

“DNAnexus’ reputation as a leader and innovator in the field of
biomedical informatics is well known in the life sciences technology
sector,” said Gibson. “I look forward to joining a strong management
team and helping drive growth and build the DNAnexus brand.”

About DNAnexus

DNAnexus, the leader in biomedical informatics and data management, has
created the global network for genomics and other biomedical data,
operating in 33 countries across North America, South America, Europe,
Asia, Australia, and Africa. The secure, scalable, and collaborative
DNAnexus Platform helps thousands of researchers across a spectrum of
industries – biopharmaceutical, bioagricultural, sequencing services,
clinical diagnostics, government, and research consortia – accelerate
their genomics programs. For more information on DNAnexus, please visit
or follow the company @DNAnexus.